Showing 1 - 20 results of 71 for search '"Gedeon Richter plc"', query time: 0.50s Refine Results
  1. 1
    RGH-397 INHIBITS THE FUNCTION OF ALPHA5 GABAA RECEPTORS WITH SLOW OFF-KINETICS AND SHOWS EFFICACY IN ANIMAL MODELS OF COGNITIVE IMPAIRMENT

    RGH-397 INHIBITS THE FUNCTION OF ALPHA5 GABAA RECEPTORS WITH SLOW OFF-KINETICS AND SHOWS EFFICACY IN ANIMAL MODELS OF COGNITIVE IMPAIRMENT by Márta Thán, László Fodor, Amrita Bobok, György Szabó, György Túrós, András Visegrády, Rita Soukupné Kedves, Gábor Kapus

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Defining the therapeutic reference range for cariprazine

    Defining the therapeutic reference range for cariprazine by M. Kapás, A. Horváth, D. Djuric, R. Csehi, Á. Barabássy

    Published 2023-03-01
    “…Kapás Employee of: Gedeon Richter Plc., A. Horváth Employee of: Gedeon Richter Plc., D. …”
    Get full text
    Article
  3. 3
    Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials

    Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials by Z.B. Dombi, K. Acsai, Á. Barabássy, B. Sebe, I. Laszlovszky, G. Vass, B. Szatmári, M. Patel, W. Earley, G. Németh

    Published 2021-04-01
    “…Németh are employees of Gedeon Richter Plc., Dr. Earley and Dr. Patel a …”
    Get full text
    Article
  4. 4
    Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data

    Cariprazine Safety in Adolescents and the Elderly: Analyses of Clinical Study Data by Balázs Szatmári, Ágota Barabássy, Judit Harsányi, István Laszlovszky, Barbara Sebe, Mónika Gál, Kazushi Shiragami, György Németh, György Németh

    Published 2020-03-01
    Get full text
    Article
  5. 5
    The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia

    The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia by I. Laszlovszky, Z.B. Dombi, Á. Balogh, Á. Barabássy, G. Vass, B. Szatmári, G. Németh

    Published 2021-04-01
    “…Németh are employees of Gedeon Richter Plc. …”
    Get full text
    Article
  6. 6
    Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase

    Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase by G. Vass, Á. Barabássy, I. Laszlovszky, B. Sebe, Z.B. Dombi, B. Szatmári, G. Németh

    Published 2021-04-01
    “…Conflict of interest Studies were funded by Gedeon Richter Plc. and Allergan Plc (prior to its acquisition by AbbVie). …”
    Get full text
    Article
  7. 7
    Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders

    Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders by Béla Kiss, István Laszlovszky, Balázs Krámos, András Visegrády, Amrita Bobok, György Lévay, Balázs Lendvai, Viktor Román

    Published 2021-01-01
    Get full text
    Article
  8. 8
    A Temperature-Controlled Switch between Fürst–Plattner Rule and Anti-Fürst–Plattner Rule Ring Opening of 2,3-Epoxy-steroids with Various Halide Sources in the Presence of Imidazolium Ionic Liquids

    A Temperature-Controlled Switch between Fürst–Plattner Rule and Anti-Fürst–Plattner Rule Ring Opening of 2,3-Epoxy-steroids with Various Halide Sources in the Presence of Imidazo... by Anita Horváth, Kristóf Bolla, Alexandra Wachtler, Lilla Maksó, Máté Papp, Sándor Mahó, Zsófia Dubrovay, János Kóti, Rita Skoda-Földes

    Published 2021-10-01
    Get full text
    Article
  9. 9
    Deciphering the scopolamine challenge rat model by preclinical functional MRI

    Deciphering the scopolamine challenge rat model by preclinical functional MRI by Gergely Somogyi, Dávid Hlatky, Tamás Spisák, Zsófia Spisák, Gabriella Nyitrai, András Czurkó

    Published 2021-05-01
    Get full text
    Article
  10. 10
    Response-related sensorimotor rhythms under scopolamine and MK-801 exposures in the touchscreen visual discrimination test in rats

    Response-related sensorimotor rhythms under scopolamine and MK-801 exposures in the touchscreen visual discrimination test in rats by Diána Kostyalik, Kristóf Kelemen, Balázs Lendvai, István Hernádi, Viktor Román, György Lévay

    Published 2022-05-01
    Get full text
    Article
  11. 11
    Disrupted Social Hierarchy in Prenatally Valproate-Exposed Autistic-Like Rats

    Disrupted Social Hierarchy in Prenatally Valproate-Exposed Autistic-Like Rats by Péter Pelsőczi, Péter Pelsőczi, Kristóf Kelemen, Cecília Csölle, Gábor Nagy, Balázs Lendvai, Viktor Román, György Lévay, György Lévay

    Published 2020-01-01
    Get full text
    Article
  12. 12
    Biomimetic synthesis and HPLC–ECD analysis of the isomers of dracocephins A and B

    Biomimetic synthesis and HPLC–ECD analysis of the isomers of dracocephins A and B by Viktor Ilkei, András Spaits, Anita Prechl, Áron Szigetvári, Zoltán Béni, Miklós Dékány, Csaba Szántay Jr, Judit Müller, Árpád Könczöl, Ádám Szappanos, Attila Mándi, Sándor Antus, Ana Martins, Attila Hunyadi, György Tibor Balogh, György Kalaus (†), Hedvig Bölcskei, László Hazai, Tibor Kurtán

    Published 2016-11-01
    Get full text
    Article
  13. 13
    Efficacy of weight loss intervention can be predicted based on early alterations of fMRI food cue reactivity in the striatum

    Efficacy of weight loss intervention can be predicted based on early alterations of fMRI food cue reactivity in the striatum by Petra Hermann, Viktor Gál, István Kóbor, C. Brock Kirwan, Péter Kovács, Tamás Kitka, Zsuzsanna Lengyel, Eszter Bálint, Balázs Varga, Csongor Csekő, Zoltán Vidnyánszky

    Published 2019-01-01
    Get full text
    Article
  14. 14
    The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials

    The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials by P. Falkai, Z. Dombi, K. Acsai, Á. Barabássy, G. Németh

    Published 2022-06-01
    “…Disclosure I am an employee of Gedeon Richter Plc. …”
    Get full text
    Article
  15. 15
    Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms

    Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms by Koen Demyttenaere, Nicolas Leenaerts, Károly Acsai, Barbara Sebe, István Laszlovszky, Ágota Barabássy, Laura Fonticoli, Balázs Szatmári, Willie Earley, György Németh, Christoph U. Correll

    Published 2022-01-01
    Get full text
    Article
  16. 16
    C-N Bond Formation by Consecutive Continuous-Flow Reductions towards A Medicinally Relevant Piperazine Derivative

    C-N Bond Formation by Consecutive Continuous-Flow Reductions towards A Medicinally Relevant Piperazine Derivative by Zsolt Fülöp, Péter Bana, István Greiner, János Éles

    Published 2021-04-01
    Get full text
    Article
  17. 17
    Benzodiazepine use during cariprazine treatment in acute schizophrenia

    Benzodiazepine use during cariprazine treatment in acute schizophrenia by C. Correll, B. Sebe, R. Csehi, K. Acsai, Á. Barabássy

    Published 2022-06-01
    “…Disclosure I am an employee of Gedeon Richter Plc. …”
    Get full text
    Article
  18. 18
    Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter‐mediated nonquantal dopamine release

    Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter‐mediated nonquantal dopamine release by Viktor Román, Rita Kedves, Kristóf Kelemen, Zsolt Némethy, Beáta Sperlágh, Balázs Lendvai, E. Sylvester Vizi

    Published 2021-11-01
    Get full text
    Article
  19. 19
    Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence

    Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence by E. Rancans, Z. B. Dombi, R. Csehi, G. Németh

    Published 2023-03-01
    “…Dombi Employee of: Gedeon Richter Plc., R. Csehi Employee of: Gedeon Richter Plc., G. …”
    Get full text
    Article
  20. 20
    AAPH or Peroxynitrite-Induced Biorelevant Oxidation of Methyl Caffeate Yields a Potent Antitumor Metabolite

    AAPH or Peroxynitrite-Induced Biorelevant Oxidation of Methyl Caffeate Yields a Potent Antitumor Metabolite by Laura Fási, Ahmed Dhahir Latif, István Zupkó, Sándor Lévai, Miklós Dékány, Zoltán Béni, Árpád Könczöl, György Tibor Balogh, Attila Hunyadi

    Published 2020-11-01
    Get full text
    Article

Search Tools: